Blog

Genetic Linkage of P8 and K1

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq December 20, 2020

The K1 Genetic Variant Affects COL6A3, a Gene Encoding a Collagen

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq November 13, 2020

The P8 Genetic Variant Affects PYROXD1, a Gene Required for Oxidative Defense

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq October 5, 2020

Peer Review Fails to Identify Errors in Inconclusive Study of Genetic Variants of Equine Muscle Genes

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq July 1, 2020

Genetic Basis of Exercise Intolerance in Arabians

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq April 20, 2020

The Px Allele of CACNA2D3 May Affect Splicing of a Component of the Voltage-Gated Calcium Channel

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq February 8, 2020

Mechanism of muscle damage in filaminopathy

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq February 1, 2020

Genetic Linkage of P2 and P4

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq January 20, 2020

Filamin C (FLNC)

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq January 13, 2020

P3 Allele of FLNC is Associated with Myofibrillar Myopathy in Horses

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq January 13, 2020

Is PSSM2 Genetic?

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq December 13, 2019

Myotilin

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq October 25, 2019

Arabian MFM

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq October 13, 2019

Polysaccharide Storage Myopathy type 2 (PSSM2)

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq October 4, 2019

Polysaccharide Storage Myopathy type 1 (PSSM1)

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq September 29, 2019

Jax

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq September 17, 2019

Negative Nitrogen Balance

By Paul Szauter, PhD, Chief Scientific Officer, EquiSeq August 16, 2019